Article metrics

Download PDFPDF

Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therapy

 

Online download statistics by month:

Online download statistics by month: January 2018 to June 2025

AbstractFullPdf
Jan 201813131
Feb 201834323
Mar 2018424316
Apr 201824248
May 201828284
Jun 201832324
Jul 201818182
Aug 201834347
Sep 201832326
Oct 201835359
Nov 201828289
Dec 201822223
Jan 2019292713
Feb 2019252512
Mar 2019524913
Apr 2019232012
May 2019313014
Jun 2019222115
Jul 201929299
Aug 2019191711
Oct 2019504515
Nov 201928267
Dec 2019494916
Jan 2020403620
Feb 2020322912
Mar 2020282712
May 2020242115
Jun 202028279
Jul 2020111127
Aug 2020191820
Sep 2020181716
Oct 2020363416
Nov 2020353512
Dec 2020666512
Jan 2021525015
Feb 202144434
Mar 202130278
Apr 2021272712
May 2021232310
Jun 2021323212
Jul 202114134
Aug 202117176
Sep 2021808421
Oct 2021232017
Nov 2021242217
Dec 202127279
Jan 2022292912
Feb 2022313011
Mar 2022434314
Apr 202210411117
May 2022495423
Jun 202220216
Jul 2022403924
Aug 202236359
Sep 2022201813
Oct 2022424116
Nov 2022211913
Dec 202228289
Jan 202325238
Feb 2023282815
Mar 202328335
Apr 2023312812
May 2023272211
Jun 2023262513
Jul 2023212115
Aug 2023303115
Sep 202317176
Oct 202332307
Nov 2023878014
Dec 202355575
Jan 202436369
Feb 202428285
Mar 2024363557
Apr 2024222222
May 2024333220
Jun 2024232313
Jul 2024232011
Aug 2024262216
Sep 2024272611
Oct 2024373825
Nov 2024525017
Dec 202449476
Jan 2025454412
Feb 20251821819
Mar 2025574719
Apr 2025373624
May 202534327
Jun 2025221
Total304829681092